RankAlpha logo
Back to Rankings

RLAY

Relay TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
RLAY vs peer average
26/100
RLAY vs. peer average (F vs. C)
Grade spread
A 1 · C 5 · D 1 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

IDYA is the first available peer comparator.

IDEAYA is a closer small-cap precision-oncology development peer by stage and valuation, though its pipeline differs; peer sentiment helps frame how much RLAY still trades on milestone timing versus marketed-product economics.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIDYAIDEAYA Biosciences
RLAY
Relay Therapeutics
IDYA
IDEAYA Biosciences
Grade
F
C
Momentum
87
68
Value
41
41
Sentiment
27
57
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs IDYA

RLAY / IDYA
Grade Position
Below peers
RLAY vs. peer average (F vs. C)
26/100
Momentum
87
RLAY
Value
41
RLAY
Sentiment
27
IDYA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RLAY
1
IDYA
IDYA
C
60/100
-2
2
ELVN
ELVN
F
20/100
Even
3
MLYS
MLYS
C
60/100
-2
4
CELC
Celcuity Inc Common
A
100/100
-4
5
MANE
Veradermics Inc Common
C
60/100
-2
IDYA is the first peer returned for this comparison set.